Profile
Michael Dey is former Chief Executive Officer & Director at Predictive Therapeutics LLC, former President at ESI Lederle and former President-Scientific Affairs at Wyeth Corp.
Dr. Dey received an undergraduate degree from Western Washington University, a graduate degree from the University of California, Davis, an undergraduate degree from the University of Washington and a doctorate from Washington State University.
Former positions of Michael Dey
Companies | Position | End |
---|---|---|
PREDICTIVE TECHNOLOGY GROUP, INC. | Director/Board Member | 2023-03-31 |
Juneau Biosciences LLC
Juneau Biosciences LLC Medical SpecialtiesHealth Technology Juneau Biosciences LLC develops and commercializes novel diagnostic and therapeutic products focused on women's health care. It is a molecular genetics company. The company was founded by Kenneth Ward in 2007 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
ESI Lederle
ESI Lederle Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., ESI Lederle is a private company that manufactures and distributes injectable drugs. The company is based in Cherry Hill, NJ. ESI Lederle was acquired by Baxter Healthcare Corp. from Wyeth LLC on December 20, 2002 for $305 million. | President | - |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Predictive Therapeutics LLC
Predictive Therapeutics LLC BiotechnologyHealth Technology Predictive Therapeutics LLC specializes in the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. It develops, commercializes, acquires, and invests in technologies involved in novel molecular diagnostic and therapeutic healthcare products. The company is headquartered in Salt Lake City, UT. | Chief Executive Officer | - |
Training of Michael Dey
University of Washington | Undergraduate Degree |
University of California, Davis | Graduate Degree |
Washington State University | Doctorate Degree |
Western Washington University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PREDICTIVE TECHNOLOGY GROUP, INC. | Health Technology |
Private companies | 4 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Juneau Biosciences LLC
Juneau Biosciences LLC Medical SpecialtiesHealth Technology Juneau Biosciences LLC develops and commercializes novel diagnostic and therapeutic products focused on women's health care. It is a molecular genetics company. The company was founded by Kenneth Ward in 2007 and is headquartered in Salt Lake City, UT. | Health Technology |
ESI Lederle
ESI Lederle Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., ESI Lederle is a private company that manufactures and distributes injectable drugs. The company is based in Cherry Hill, NJ. ESI Lederle was acquired by Baxter Healthcare Corp. from Wyeth LLC on December 20, 2002 for $305 million. | Health Technology |
Predictive Therapeutics LLC
Predictive Therapeutics LLC BiotechnologyHealth Technology Predictive Therapeutics LLC specializes in the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. It develops, commercializes, acquires, and invests in technologies involved in novel molecular diagnostic and therapeutic healthcare products. The company is headquartered in Salt Lake City, UT. | Health Technology |